BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nivolumab
1
Efficacy and safety of nivolumab plus chemotherapy in patients with advanced gastric cancer with massive ascites
1/12/2026 10:07:37 AM | Browse: 76 | Download: 220
2
Clinical observation of nivolumab combined with cabozantinib in the treatment of advanced hepatocellular carcinoma
3/25/2025 4:18:46 PM | Browse: 132 | Download: 720
3
Differentiating between immune checkpoint inhibitor-induced myocarditis and cardiac metastasis in a cardio-oncology patient presenting with myocardial infarction: A case report
1/21/2025 8:51:50 AM | Browse: 104 | Download: 628
4
Downstaging of advanced hepatocellular carcinoma followed by liver transplantation using immune checkpoint inhibitors: Where do we stand?
9/3/2024 8:54:07 AM | Browse: 166 | Download: 561
5
Nivolumab-induced tumour-like gastritis: A case report
6/26/2023 8:57:14 PM | Browse: 349 | Download: 1281
6
Immune-related adverse events induced by programmed death protein-1 inhibitors from the perspective of lymphoma immunotherapy
3/2/2023 1:29:51 PM | Browse: 425 | Download: 1054
7
Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab
12/14/2022 7:20:14 AM | Browse: 495 | Download: 1087
8
Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast
9/22/2022 6:32:13 AM | Browse: 575 | Download: 1323
9
Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma
8/26/2022 9:51:35 AM | Browse: 559 | Download: 1402
10
Necessity of neutrophil-to-lymphocyte ratio monitoring for hypothyroidism using nivolumab in patients with cancer
7/22/2022 9:38:18 AM | Browse: 613 | Download: 1675
11
Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: A case report
7/5/2022 1:22:30 AM | Browse: 644 | Download: 1625
12
Tsunami of immunotherapy reaches mesothelioma
4/22/2022 8:49:02 AM | Browse: 629 | Download: 1522
13
Combined targeted therapy and immunotherapy in anaplastic thyroid carcinoma with distant metastasis: A case report
4/21/2022 11:35:30 AM | Browse: 641 | Download: 1915
14
Tumor-related cytokine release syndrome in a treatment-naïve patient with lung adenocarcinoma: A case report
2/11/2022 5:55:20 AM | Browse: 612 | Download: 1801
15
Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
11/10/2021 7:13:09 AM | Browse: 874 | Download: 2366
16
Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report
10/14/2020 1:53:48 PM | Browse: 873 | Download: 2527
17
Severe steroid refractory gastritis induced by Nivolumab: A case report
4/28/2020 8:04:31 AM | Browse: 1195 | Download: 2500
18
Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review
1/16/2020 7:58:40 AM | Browse: 1057 | Download: 2108
19
Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report
10/25/2019 8:06:40 AM | Browse: 939 | Download: 1825
20
Pseudo- or real progression? An ovarian cancer patient under nivolumab: A case report
7/24/2019 7:32:48 AM | Browse: 1012 | Download: 1751
21
Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report
1/21/2019 9:20:19 AM | Browse: 1498 | Download: 2075
22
Endoscopic evaluation of immunotherapy-induced gastrointestinal toxicity
12/21/2018 6:09:14 AM | Browse: 1127 | Download: 2022
23
Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
5/15/2018 7:28:22 AM | Browse: 1478 | Download: 1927
24
Systemic treatment of hepatocellular carcinoma: Past, present and future
6/20/2017 12:50:09 PM | Browse: 1441 | Download: 2150
25
Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate
4/7/2017 8:24:12 AM | Browse: 1269 | Download: 1846
26
Present and future of immune checkpoint blockade: Monotherapy to adjuvant approaches
3/31/2015 10:55:00 AM | Browse: 1405 | Download: 1648
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.